Beta
162986

SUBCONJUCTIVAL INJECTION OF BEVACIZUMAB IN CORNEAL NEOVASCULARIZATION

Article

Last updated: 23 Jan 2023

Subjects

-

Tags

-

Abstract

Purpose: The aim of this work was to assess the outcome of subconjunctival bevacizumab
(Avastin) injection in patients with corneal neovascularization (NV).
Methods: Twenty eyes of
twenty patients (13 male and 7 female) with corneal neovascularization resulted from variable
ocular surface disorders were included in this prospective, non-controlled study. All eyes
received a single subconjunctival injection of 2.5 mg (0.1 ml) bevacizumab using 1 ml syringe
27 Guage needle. Morphological changes in the major and minor vessels were studied by slitlamp biomicroscopy and corneal photography pre-injection and one week, 2 months and 6
months post injection.
Results: Obvious recession of minor vessels of Corneal NV was noticed
in most eyes at first week post-injection. The extent of corneal neovascularization of the major
vessels was significantly decreased 1weeks post-injection. This decrease continued noticeably
for 6 months.
Conclusions: Bevacizumab can be safely and effectively used in corneal NV
treatment. It can be considered in the treatment of both minor and major vessel NV resulted
from long standing chronic inflammation (trachoma), long-standing corneal ischemia (following
contact lens wear) and other different causes. Bevacizumab was well tolerated over the
monitoring period in this research. Further controlled and long term studies are required to fully
evaluate the long term effects of this recent treatment.


DOI

10.21608/ejco.2019.162986

Keywords

Corneal neovascularization, Avastin, Subconjunctival injection

Authors

First Name

Ali,

Last Name

Kh.

MiddleName

-

Affiliation

Ophthalmology dept., Faculty of Medicine, AL-Azhar Univ., Assuit, Egypt

Email

-

City

-

Orcid

-

First Name

Abd El-badie,

Last Name

M.

MiddleName

-

Affiliation

Ophthalmology dept., Faculty of Medicine, AL-Azhar Univ., Assuit, Egypt

Email

-

City

-

Orcid

-

First Name

Hassan,

Last Name

H.

MiddleName

-

Affiliation

Ophthalmology dept, Faculty of Medicine, AL-Azhar Univ. Cairo, Egypt

Email

-

City

-

Orcid

-

Volume

2

Article Issue

2

Related Issue

23739

Issue Date

2019-12-01

Receive Date

2019-09-01

Publish Date

2019-12-01

Page Start

69

Page End

74

Print ISSN

2537-0502

Online ISSN

2537-0944

Link

https://ejco.journals.ekb.eg/article_162986.html

Detail API

https://ejco.journals.ekb.eg/service?article_code=162986

Order

4

Type

Original articles: include clinical trials, interventional research, Basic researches and clinically relevant laboratory investigations

Type Code

1,824

Publication Type

Journal

Publication Title

Egyptian Journal of Clinical Ophthalmology

Publication Link

https://ejco.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

23 Jan 2023